Been watching KCI for a Covered Call play for a week or so...
GOOD THING I DID NOT DO IT!
Jury verdict on a patent infringement has knock it down about 40% this morning..
KCI ANNOUNCES JURY VERDICT IN PATENT CASE
SAN ANTONIO -- (BUSINESS WIRE) -- August 3, 2006 -- Kinetic Concepts, Inc.
(NYSE:KCI) announced today that a U.S. District Court jury has found that the
Wake Forest patents involved in the litigation against BlueSky Medical Group,
Inc. and Medela AG are valid and enforceable. The jury also found that the
patent claims involved in the case are not infringed by the Versatile 1 system
marketed by BlueSky. The Wake Forest patents relate to KCI's V.A.C. technology
used for the treatment of patients with serious, complex wounds.
KCI intends to challenge the finding of non-infringement before the trial court
and on appeal, and there are likely to be significant post-verdict motions and
hearings. The Court has not yet set a post-verdict schedule, and will issue its
final judgment in future proceedings.
"The jury verdict confirms our belief that the fundamental intellectual
property covering our revolutionary V.A.C. technology is valid and enforceable,
although we plan to challenge the finding of non-infringement," said Dennert O.
Ware, KCI's President and Chief Executive Officer.
GOOD THING I DID NOT DO IT!
Jury verdict on a patent infringement has knock it down about 40% this morning..
KCI ANNOUNCES JURY VERDICT IN PATENT CASE
SAN ANTONIO -- (BUSINESS WIRE) -- August 3, 2006 -- Kinetic Concepts, Inc.
(NYSE:KCI) announced today that a U.S. District Court jury has found that the
Wake Forest patents involved in the litigation against BlueSky Medical Group,
Inc. and Medela AG are valid and enforceable. The jury also found that the
patent claims involved in the case are not infringed by the Versatile 1 system
marketed by BlueSky. The Wake Forest patents relate to KCI's V.A.C. technology
used for the treatment of patients with serious, complex wounds.
KCI intends to challenge the finding of non-infringement before the trial court
and on appeal, and there are likely to be significant post-verdict motions and
hearings. The Court has not yet set a post-verdict schedule, and will issue its
final judgment in future proceedings.
"The jury verdict confirms our belief that the fundamental intellectual
property covering our revolutionary V.A.C. technology is valid and enforceable,
although we plan to challenge the finding of non-infringement," said Dennert O.
Ware, KCI's President and Chief Executive Officer.